Why Do Clinical Trial Startup Delays Still Happen Despite More Technology?
Clinical trial study startup has become increasingly technology-enabled, yet sponsors, contract research organizations (CROs), and research sites still face persistent
study collaboration
Improving Clinical Trial Site Collaboration with Connected Study Startup Workflows
Clinical trial study startup requires constant coordination across sponsors, contract research organizations (CROs), research sites, and institutional review boards (IRBs).
A More Connected Approach to Clinical Trials: Reducing Friction from Study Design Through Conduct
Clinical trials are complex. That’s expected, given accelerated advancements in science and technology. But when that complexity creates friction in
Simplifying Oversight and Managing Regulatory Complexity in Multi-Site Clinical Trials
Traditional clinical trial designs often delay progress due to rigid protocols and frequent amendments. Adaptive and platform trial models introduce flexibility and shared infrastructure, reducing startup delays, cutting costs, and enabling sponsors to conduct faster, more efficient research.
Live Demo: Introducing Site-Facing SSU Milestone Tracking
Join experts from Johnson & Johnson Innovative Medicine, Bayer, The START Center for Cancer Care, and Advarra to discuss the ethical use of real-world data in clinical research.
Improving Clinical Tech Adoption: Site-Centric Approaches
Join experts from Johnson & Johnson Innovative Medicine, Bayer, The START Center for Cancer Care, and Advarra to discuss the ethical use of real-world data in clinical research.